Physician

Kenneth Patrick Martinez, M.D.

According to 2025 Medicare claims, Kenneth Martinez, M.D. (NPI: 1093825259) practices neurology in the Anaheim-Santa Ana-Irvine, CA market, with the plurality of this provider's patient population coming from Orange, CA. This provider's primary affiliated billing organization is KENNETH P MARTINEZ MD A MEDICAL CORP (NPI: 1255537957; TIN: 061639452) and primary practice location at 92656-5332. Martinez is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Martinez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,104 traditional Medicare patients, billed 199,626 HCPCS/CPT codes, and received $1,849,920 in Medicare payments. The top billing code was 95912 (Nerve conduction, 11-12 studies). Part D data shows 2,959 prescription claims across 446 beneficiaries totaling $2,186,533 in drug costs, led by Panzyga (Immun Glob G(Igg)-Ifas/Glycine). DME data shows 34 claims. Open Payments data shows 366 records totaling $50,671. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $925,602 to $1,849,920. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $729,704 to $2,186,533. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $13,822 and ending at $4,820.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$925K$1.8M2015 Medicare payment: $925,602 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,009,913 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,084,141 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,131,285 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,195,477 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,315,883 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,331,037 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,398,998 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,620,284 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,849,920 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201572273,294$925,602
201674484,038$1,009,913
201777678,803$1,084,141
201879693,706$1,131,285
2019822102,412$1,195,477
2020834103,812$1,315,883
2021888123,571$1,331,037
2022978132,424$1,398,998
2023999162,353$1,620,284
20241,104199,626$1,849,920

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1M$2.3M2015 Drug cost: $729,704 (USD; Tot_Drug_Cst)2016 Drug cost: $1,523,553 (USD; Tot_Drug_Cst)2017 Drug cost: $1,172,696 (USD; Tot_Drug_Cst)2018 Drug cost: $1,089,628 (USD; Tot_Drug_Cst)2019 Drug cost: $923,101 (USD; Tot_Drug_Cst)2020 Drug cost: $1,081,879 (USD; Tot_Drug_Cst)2021 Drug cost: $1,546,884 (USD; Tot_Drug_Cst)2022 Drug cost: $1,827,469 (USD; Tot_Drug_Cst)2023 Drug cost: $2,299,421 (USD; Tot_Drug_Cst)2024 Drug cost: $2,186,533 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152982,825$729,704
20163122,908$1,523,553
20172832,688$1,172,696
20183032,590$1,089,628
20193592,452$923,101
20204032,656$1,081,879
20213772,744$1,546,884
20224152,932$1,827,469
20234853,456$2,299,421
20244462,959$2,186,533

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$43K$86K2015 Medicare payment: $75,151 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $85,626 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $79,760 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $75,076 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $80,241 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $52,884 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $690 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,705 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R68$75,151
2016N/R101$85,626
2017N/R17$79,760
2018N/R16$75,076
2019N/R55$80,241
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R84$52,884
2023N/R33$690
2024N/R34$1,705

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
95912Nerve conduction, 11-12 studies198263$222
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more274274$144
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more7681,573$110
99424Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month.7021,985$72
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's212324$14

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PanzygaImmun Glob G(Igg)-Ifas/Glycine26728$479,476
GammaplexImmun Glob G(Igg)/Gly/Iga 0-50401,064$385,461
IngrezzaValbenazine Tosylate17750$195,810
Gamunex-CImmune Globul G/Gly/Iga Avg 4611308$95,619
GammakedImmune Globul G/Gly/Iga Avg 4612336$90,160

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1805Dynamic adjustable wrist extension / flexion device, includes soft interface materialYN/R11$1,014
E0260Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattressYN/R12$560
K0001Standard wheelchairYN/R11$132

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.361$41,215ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.5$9,456ABBVIE INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kenneth Patrick Martinez, M.D.?

Tedicare shows public-source Medicare data for Kenneth Patrick Martinez, M.D. (NPI 1093825259), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kenneth Patrick Martinez, M.D. have ACO affiliation data?

Kenneth Patrick Martinez, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Kenneth Patrick Martinez, M.D.?

Kenneth Patrick Martinez, M.D. is linked to KENNETH P MARTINEZ MD A MEDICAL CORP (billing NPI 1255537957) in the available physician profile data.

Does Kenneth Patrick Martinez, M.D. have Open Payments data?

Kenneth Patrick Martinez, M.D. has 366 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.